Cellectar Biosciences stock price
셀렉타 바이오사이언시스NASDAQ:CLRB · Nasdaq · Healthcare$1.78-4.81%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Cellectar Biosciences last closed at $1.78 (-4.81%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -1.0×. Its overall grade ranks 626 of 739 stocks in Healthcare.
About this company
Cellectar Biosciences last closed at $1.78 (-4.81%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall D · 626/739
Valuation grade C+
Related stocks
- Jazz PharmaceuticalsCustomer
Cellectar의 방사성의약품/항암 파이프라인과 잠재적으로 협업·라이선스 가능한 항암 치료제 기업
- NovartisCompetitor
방사성의약품·표적항암제 개발에서 경쟁 가능한 글로벌 제약사
- Bristol Myers SquibbCompetitor
혈액암·항암제 시장에서 직접 경쟁하는 대형 제약사
About Cellectar Biosciences
- What technical signals does Cellectar Biosciences (CLRB) have?
- Cellectar Biosciences current technical signals: no active technical signal.
- Is Cellectar Biosciences a cup-and-handle pattern?
- No. Cellectar Biosciences has no valid Cup signal right now.
- What published figures are available for Cellectar Biosciences?
- Market cap: $7.55M. Trailing 12 months PER: -1.0×. Latest quarter PBR: 0.73×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Cellectar Biosciences, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy